EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Time‐Controlled Refrigerated Stem Cell Therapy Mitigates Scleroderma Fibrosis via Modulation of Mitochondrial Autophagy and Gut Metabolism

Xue Xia, Chenfei Kong, Xiaoming Zhao, Naixu Shi, Jinlan Jiang, Ping Li iD

Advanced Science · 2026

DOI: 10.1002/advs.202515505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xue Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, China-Japan Union Hospital, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Scleroderma, Systemic, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Health Research Talent Project, Jilin Province Science and Technology Development Plan Project, Jilin University Sino-Japanese Friendship Hospital Spring Bud Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scleroderma is a chronic autoimmune disease characterized by progressive fibrosis, associated with high morbidity and mortality, limited therapeutic efficacy, and significant systemic side effects. Therefore, there is an urgent need to develop novel treatment strategies with improved tissue targeting and safety profiles. In this study, a refrigerated‐treated mesenchymal stem cell (RT‐MSCs) system was established by culturing human umbilical cord‐derived MSCs under controlled low‐temperature conditions. The antifibrotic effects of RT‐MSCs were evaluated through both in vivo and in vitro experiments, together with an assessment of their regulatory role in mitochondrial autophagy. Their lesion‐targeting capacity was also investigated. Furthermore, the effects of RT‐MSCs on gut microbiota composition and metabolic pathways in model mice were comprehensively analyzed using 16S rRNA sequencing and intestinal content metabolomics, and the safety of RT‐MSCs was systematically evaluated. The results demonstrated that RT‐MSCs effectively attenuated fibrosis progression by modulating mitochondrial autophagy. Within 30 min after administration, RT‐MSCs accumulated at lesion sites and persisted for up to 7 days. RT‐MSCs significantly improved intestinal microbiota dysbiosis in scleroderma mice and regulated the expression of associated intestinal metabolites. In summary, as an optimized stem cell‐based therapeutic strategy, RT‐MSCs offer new insights and potential avenues for treating scleroderma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationScleroderma, SystemicMitochondriaGastrointestinal TractRefrigerationMice, Inbred C57BLHumansFemaleAnimalsMiceAutophagyDisease Models, AnimalGastrointestinal MicrobiomeMetabolomeMetabolomicsSequence Analysis, RNA

Stichwörter der Autor:innen

gut microbiotaintestinal content metabolomicsmesenchymal stem cellsmitophagytargeting specificity

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Department of Stomatology, China-Japan Union Hospital of Jilin University, Changchun, China.

ORCID-Profile: Ping Li

Förderung

  • Jilin Province Health Research Talent Project
  • Jilin Province Science and Technology Development Plan Project
  • Jilin University Sino-Japanese Friendship Hospital Spring Bud Program
  • The Jilin Province Science and Technology Development Program

Zitieren

APA

Xia, X., Kong, C., Zhao, X., Shi, N., Jiang, J., & Li, P. (2026). Time‐Controlled Refrigerated Stem Cell Therapy Mitigates Scleroderma Fibrosis via Modulation of Mitochondrial Autophagy and Gut Metabolism. Advanced Science. https://doi.org/10.1002/advs.202515505

Vancouver

Xia X, Kong C, Zhao X, Shi N, Jiang J, Li P. Time‐Controlled Refrigerated Stem Cell Therapy Mitigates Scleroderma Fibrosis via Modulation of Mitochondrial Autophagy and Gut Metabolism. Advanced Science. 2026. doi:10.1002/advs.202515505

BibTeX
@article{Xia2026,
  author = {Xia, Xue and Kong, Chenfei and Zhao, Xiaoming and Shi, Naixu and Jiang, Jinlan and Li, Ping},
  title = {Time‐Controlled Refrigerated Stem Cell Therapy Mitigates Scleroderma Fibrosis via Modulation of Mitochondrial Autophagy and Gut Metabolism},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202515505}
}
Kostenlos starten →